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ABSTRACT
Type IIA topoisomerases modify DNA topology
by passing one segment of duplex DNA (transfer
or T–segment) through a transient double-strand
break in a second segment of DNA (gate or
G–segment) in an ATP-dependent reaction. Type
IIA topoisomerases decatenate, unknot and relax
supercoiled DNA to levels below equilibrium, result-
ing in global topology simplification. The mechan-
ism underlying this non-equilibrium topology
simplification remains speculative. The bend angle
model postulates that non-equilibrium topology
simplification scales with the bend angle imposed
on the G–segment DNA by the binding of a type
IIA topoisomerase. To test this bend angle model,
we used atomic force microscopy and single-
molecule Fo ¨rster resonance energy transfer to
measure the extent of bending imposed on DNA by
three type IIA topoisomerases that span the range of
topology simplification activity. We found that
Escherichia coli topoisomerase IV, yeast topoisom-
erase II and human topoisomerase IIa each bend
DNA to a similar degree. These data suggest that
DNA bending is not the sole determinant of
non-equilibrium topology simplification. Rather,
they suggest a fundamental and conserved role for
DNA bending in the enzymatic cycle of type IIA
topoisomerases.
INTRODUCTION
Topoisomerases are enzymes that modify and regulate
the topology of cellular DNA (1–5). The regulation of
DNA topology is essential in all organisms since vital
cell processes, such as DNA replication and transcription,
give rise to a myriad of topological problems, including
knotting, catenation and excess supercoiling of genomic
DNA.
Type I topoisomerases cut a single strand of DNA
through an ATP-independent mechanism that allows for
the relaxation of supercoils and, in some cases, passage of
duplex DNA through a nick (2). Type II topoisomerases,
on the other hand, cut both strands of one segment of
DNA (gate or G–segment) and pass a second seg-
ment (transfer or T–segment) through the transient
double-strand break via an ATP-dependent mechanism
(Figure 1A) (1–3,5). This two-gate mechanism results in
unidirectional strand passage (6,7). Though they share a
similar core strand passage mechanism, the type II topo-
isomerase subclasses, type IIA and type IIB, are struc-
turally, biochemically and evolutionarily distinct (8–10).
Type IIA topoisomerases are capable of relaxing and
introducing supercoils, as well as generating and removing
intramolecular and intermolecular links, i.e. knots and
catenanes. Type IIA topoisomerases play a fundamental
role in chromosome segregation during cell division by
unlinking catenated sister chromatids thus enabling
daughter cells to receive the proper complement of
chromosomes (3). They are also likely required to reduce
the level of DNA knotting that is expected in highly com-
pacted DNA, which would have deleterious consequences
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isomerases facilitate these critical unlinking and unknotting
processes via a strand-passage mechanism, random strand-
passage would not lead to speciﬁc and complete unlinking
and unknotting (15). Rather, it would result in a dynamic
equilibrium between linking and unlinking reactions.
Rybenkov et al. (15) showed that non-supercoiling type
IIA topoisomerases (i.e. type IIA topoisomerases with
the exception of DNA gyrase, which negatively supercoils
DNA) simplify the global topology of DNA, shifting it
away from an equilibrium distribution of catenanes,
knots and supercoils toward a less entangled topology.
An equilibrium distribution, referred to as topological
equilibrium, of knots, catenanes and supercoils is
achieved if every encounter between two DNA segments
has an equal probability of resulting in strand passage.
Because type I topoisomerases do not consume energy,
they shift DNA topology toward equilibrium. In
contrast, type IIA topoisomerases can shift global
topology away from equilibrium, which implies that they
couple topology sensing to strand passage to achieve pref-
erential simpliﬁcation of knots, catenanes and supercoils.
Since type IIA topoisomerases consume ATP, thermo-
dynamic principles are not violated, but the mechanism
by which the energy of ATP hydrolysis is coupled to
topology simpliﬁcation remains elusive (16). Speciﬁcally,
it is unclear how an enzyme that acts on the scale of nano-
meters is able to assess the global topology of DNA. If the
enzyme only interacts with a single DNA crossing, how is
it able to determine that a strand passage event would
result in the removal, rather than the creation, of a
linkage (Figure 1B)?
Several mechanistic models of topology simpliﬁcation
by type IIA topoisomerases have been proposed
(15, 17–21), though to date the experimental evidence dis-
tinguishing them has been equivocal (22). One of the
leading and theoretically well-characterized models is the
G–segment bend angle model. This model, originally
proposed by Vologodskii et al. (19) and later expanded
upon by Klenin et al. (20), postulates that non-
supercoiling type IIA topoisomerases introduce a sharp
bend in the G–segment DNA that localizes the active
site of the enzyme to the interior apex of the bent DNA
(Figure 1C). The bend orients the topoisomerase such that
the T–segment binding site of the enzyme tends to point
toward the inside of circular DNA, favoring strand pas-
sage from the interior to the exterior of the circle. This
geometric selection, coupled with the unidirectional strand
passage embodied in the two gate mechanism of type IIA
topoisomerases, would lead to preferential unlinking,
unknotting and supercoil relaxation. The bend angle
model further postulates that topology simpliﬁcation
activity scales with the magnitude of the imposed bend
angle, providing a mechanistic basis for the observed vari-
ation in non-equilibrium simpliﬁcation activities among
different type IIA topoisomerases (15,16).
Recent studies, including structures of gram positive
Streptococcus pneumoniae topoisomerase IV (23) and
AC
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Figure 1. The interaction of type IIA topoisomerases with DNA. (A) Core strand-passage mechanism for type IIA topoisomerases [adapted from
Bates and Maxwell (7)]. (1) Type IIA topoisomerase (blue, yellow and orange) binds duplex G–segment DNA (green). (2) A second duplex, T–
segment DNA, (pink to red, denoting movement of the DNA) subsequently binds to the topoisomerase. (3) Upon binding two ATP molecules
(asterisks), the N–gate (yellow) closes, trapping the T–segment inside the ATP-binding ‘clamp’ and the G–segment is cleaved, permitting passage of
the T–segment. (4) The G–segment is religated, and the T–segment is released from the C–gate (blue) of the topoisomerase. ATP hydrolysis products,
ADP and Pi, are then released, resetting the enzyme for another strand passage event. (B) A topoisomerase located at a single DNA crossing cannot
directly differentiate between an unlinked and a linked conformation. (C) The bend angle model posits that a type IIA topoisomerase induces a sharp
bend in the G–segment DNA, orienting the active site of the enzyme toward the interior of the bend. This geometry favors the capture of a T–
segment from inside rather than outside the bend. (D) The bend angle,  , is deﬁned as the angle through which the DNA is bent from a straight line.
The opening angle,  , measured between the two DNA segments emerging from the topoisomerase, is the supplement of the bend angle, hence
 =180 –  .
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(24), both co-crystallized with DNA in a covalently bound
cleavage complex, structures of yeast topoisomerase II
(yTopo II) co-crystallized both with non-covalently
bound DNA (25) and in a covalently bound DNA
cleavage complex (26), and single-molecule magnetic
tweezers measurements (27), indicate that DNA is bent
by type IIA topoisomerases. Though these studies lend
support to the bend angle model, other studies give
contradictory results. For instance, recent simulations
using an improved worm-like chain (WLC) model have
shown that a sharply bent conformation of the
G–segment DNA is not sufﬁcient to reproduce experimen-
tal non-equilibrium topology simpliﬁcation results (28,29).
Also, an implication of the bend angle model is that
topology simpliﬁcation activity should depend on DNA
circle size. Decreasing the circle size should increase the
probability that a bend would orient the active site of the
enzyme toward the interior of the circle. This, in turn,
would be expected to amplify the effect of the bend
angle, thereby enhancing topology simpliﬁcation activity.
However, the non-equilibrium activity of yTopo II and
Escherichia coli topoisomerase IV (Topo IV) appear to
be independent of DNA circle size for circles large
enough to adopt more than two topoisomer conform-
ations (16,21). Although these various results either indir-
ectly support or contradict the bend angle model, the
speciﬁc predictions of the model have not been tested
directly (22).
In this study, we used atomic force microscopy (AFM)
to image type IIA topoisomerase-DNA complexes and
directly measure the bend angles imposed on the DNA
by three non-supercoiling type IIA topoisomerases that
span the range of topology simpliﬁcation activity:
Topo IV, human topoisomerase IIa (hTopo IIa) and
yTopo II, in order of decreasing non-equilibrium
topology simpliﬁcation activity (15,16). We also used
ensemble and single-molecule Fo ¨ rster resonance energy
transfer (FRET) to probe the extent of DNA bending
by these three topoisomerases. According to the bend
angle model, Topo IV, which has the largest simpliﬁcation
activity, should impose the largest bend in DNA, whereas
yTopo II, which has the smallest simpliﬁcation activity,
should impose the smallest bend (20). The bend angles
imposed on the DNA by each of these proteins
measured by AFM and computed from FRET efﬁciencies
were compared to those predicted by the bend angle
model. We found that all three type IIA topoisomerases
bent the DNA to a similar degree. Moreover, for each
enzyme, with the possible exception of yTopo II, the
extent of the bending was less than predicted by the
bend angle model, which suggests that G–segment DNA
bending is unable to fully account for the topology sim-
pliﬁcation behavior of these enzymes.
MATERIALS AND METHODS
Enzymes and DNA substrates
yTopo II and hTopo IIa were puriﬁed as previously
described (30,31). ParC and ParE subunits of Topo IV
were puriﬁed as previously described (32) with minor
modiﬁcations. Brieﬂy, the cell pellet was resuspended in
20mM HEPES (pH 7.5), 400mM NaCl, 10% glycerol and
2mM b-mercaptoethanol, lysed by sonication and
centrifuged. The supernatant was loaded onto a HisTrap
HP column (GE Healthcare, Piscataway, NJ, USA) and
the protein was eluted with a linear gradient of 0–200mM
imidazole. The protein containing fractions were pooled
and desalted on a HiPrep desalting column (GE
Healthcare). The His-tag was removed by overnight incu-
bation with AcTEV (33) at 4 C using an OD280nm ratio of
1:100 AcTEV:protein and the cleaved protein was ﬁltered
through a HisTrap HP column. The protein was
concentrated and further puriﬁed on a Superdex 200 10/
300 GL column (GE Healthcare). ParC and ParE were
quantiﬁed by UV absorption, and the complexes were
assembled by incubating equimolar quantities of ParC
and ParE subunits on ice.
The AFM—DNA substrates are illustrated in Figure 2.
Substrates D1 and D2 are 404 and 393 base pairs (bp)
long, respectively, and each contains one of two putative
Topo IV binding sequences as determined by Marians and
Hiasa (34). Putative binding sequence one (PBS–1) is 50–G
GGCCACTCCTAAAAATCCGGGGTATACCCCGGA
TTTTTAGGAGTGGCCCGAACCGTTCG–30, and
putative binding sequence two (PBS–2) is 50–CGCACG
GGCCCTAAATAGGGGGGTATACCCCCCTATTTA
GAACCGGTTCG–30. Substrate D1 was developed by
inserting PBS–1 into pUC19 plasmid (New England
Biolabs, Ipswitch, MA, USA) between the EcoRI and
BamHI restriction sites. The resulting plasmid was
ampliﬁed by PCR using Phusion DNA polymerase (New
England Biolabs), with oligonucleotide primers FOR–1
(50–GGAGAAAATACCGCATCAGGCGCC–30) and
REV–1 (50–TGTGAGTTAGCTCACTCATTAGGCAC
Figure 2. DNA substrates used for AFM imaging. D1 and D2 contain
putative Topo IV binding sequences PBS–1 and PBS–2, respectively
(see main text for sequence). D3–D5 were digested with the restriction
enzyme indicated. D6 is identical in sequence to D3 and D4 but
undigested. All DNA substrates were made by PCR, based on the
multiple cloning site of pUC19 plasmid.
Nucleic Acids Research, 2011,Vol.39, No. 13 5731CC–30). Substrate D2 was constructed in the same manner
as D1, but contained PBS–2. Substrates D3 and D4 were
designed to improved binding afﬁnity. They are 360bp
long but include a 4bp staggered double-stranded break
at or near the middle of the molecule. Position 217–576 of
plasmid pUC19 was ampliﬁed by PCR, using primers
FOR–1 and REV–1 as described above, and digested
with either EcoRI to make D3, XmaI to make D4, or
left intact as a control, D6. EcoRI and XmaI were used
to vary the sequence of the 4bp overhang. D5 consists of
position 279–550 of pUC19, ampliﬁed by PCR using
oligonucleotide primers FOR–2 (50–TCGGTGCGGGCC
TCTTCGC–30) and REV–2 (50–CCCAGGCTTTACACT
TTATGCTTCCGGCTCG–30). This substrate is 272bp
long and was digested by XmaI at its restriction site,
producing equal 136bp fragments. This is a symmetric
version of D4 since it contains much of the same
sequence and is cut with the same restriction enzyme.
All restriction endonucleases were obtained from New
England Biolabs.
DNA substrates used in single-molecule FRET experi-
ments, F1 and F2, were adapted from Dong et al. (25) but
were lengthened to prevent interaction between the protein
and the surface of the glass slide. As shown in Figure 3A,
ﬂuorescent DNA substrates F1 and F2 contain a com-
plementary 4bp overhang that allowed the transiently
annealed region to be stabilized by a bound topoisomer-
ase and thus generate a FRET signal. Substrate F1
contains an Alexa647 ﬂuorophore at the 50 blunt end
of the segment. The sequence of the top strand of F1 is:
50–[Alexa647]-GCGCCGAGGATGACGATG–30. The
sequence of the complementary bottom strand of this sub-
strate is: 30–CGCGGCTCCTACTGCTAC|GCCC–50,
where the ‘|’ denotes the beginning of the 4bp overhang
(Figure 3A). Substrate F2 contains an internal Alexa546
ﬂuorphore, located the same distance from the 4bp
overhang as the Alexa647 on F1 and a biotin at the 30
blunt end. The sequence of the top strand of F2 is: 50–
CGGG|CATCGTCATCCTCGGCGCCGTGCGTAAC
TGTCCGCCCTGCTGCGAGTGG-[Biotin]–30, where
the ‘|’ denotes the beginning of the 4bp overhang. The
sequence of the complementary bottom strand is 30–GT
AGCAGTAGGAGCCGCG-[Alexa546]-GCACGCATT
GACAGGCGGGACGACGCTCACC–50 (Figure 3A).
Each of these oligos, including the ﬂuorophores and
biotin, was synthesized by Euroﬁns MWG Operon
(Huntsville, AL, USA).
Relaxation assays
Wheat germ topoisomerase I (Topo IB) (Promega,
Madison, WI, USA), Topo IV, yTopo II and hTopo IIa
were incubated with plasmid pBR322 (New England
Biolabs) at protein: DNA concentrations of 25nM:
50nM in a 60ml reaction containing 40mM Tris–HCl
(pH 7.5), 6mM MgCl2, 100mM KOAc, 1mM DTT,
1mM ATP, 0.1mM EDTA and 50mg/ml bovine serum
albumin (BSA) (New England Biolabs). Unless otherwise
noted, all chemicals were obtained from Sigma-Aldrich
(St Louis, MO, USA). Reactions were incubated over-
night at 37 C and stopped with a buffer containing
0.1% SDS, 10mM EDTA and TrackIt
TM Cyan/Yellow
Loading Buffer (Invitrogen, Carlsbad, CA, USA). A 1%
Tris–Acetate EDTA (TAE) agarose gel containing 1mg/ml
chloroquine was loaded with 10ml of reaction. Gels were
run overnight at 2.5 V/cm at 4 Ci n1   TAE supple-
mented with 1mg/ml chloroquine to resolve topoisomers,
destained in water for 2h to remove chloroquine, and
stained for 40min in a solution of 1  SYBR Green I
A
B
Figure 3. Schematics of single-molecule FRET experiments. (A) DNA used in single-molecule FRET experiments showing locations of the
ﬂuorophores, Alexa546 and Alexa647, biotin and double-stranded overhang. (B) Schematic representation of a type IIA topoisomerase bending
the FRET substrate. The distance between the ﬂuorophores (r) was determined from the FRET efﬁciency measurements [Equation (3)] and related to
the bend angle using the relationship shown in Equation (4). Here, rc is the length of the unbent DNA segment between the two bent DNA segments
and rtot (not labeled) is the contour length of DNA between the two ﬂuorophores.
5732 Nucleic Acids Research, 2011,Vol.39, No. 13nucleic acid stain prior to imaging with a Biospectrum
AC Imaging System (UVP, Upland, CA, USA).
VisionworksLS (UVP) and ImageJ (National Institutes
of Health, Bethesda, MD, USA) software were used to
obtain and analyze gel intensity proﬁles.
Protein–DNA complex formation
Topo IV (300nM-2.4mM) and DNA (60nM-480nM)
were incubated on ice for 30min, at a protein:DNA
ratio of 5:1 for all reactions. Binding buffers 1–4: BB1
[50mM HEPES (pH 7.5), 5mM MgCl2, 50mM NaCl,
and 5% v/v glycerol], BB2 [50mM Tris–HCl (pH 7.5),
10mM MgCl2, 20mM KCl, 5mM DTT and 2.5% v/v
glycerol], BB3 [50mM Tris–HCl (pH 7.5), 10mM
MgCl2, 10mM KCl, 5mM DTT and 2.5% v/v glycerol],
and BB4 [50mM Tris–HCl (pH 7.5), 10mM CaOAc,
12.5mM sodium malonate, 5mM DTT and 5% v/v
glycerol] were used for the incubation reactions of
Topo IV with DNA substrates D1–D5. Some of the
Topo IV–DNA reactions in BB1 and BB2 were supple-
mented with 50mM quinolone (norﬂoxacin, ciproﬂoxacin
or levoﬂoxacin). yTopo II and hTopo IIa were incubated
with DNA substrates D4 and D5 under the same condi-
tions as Topo IV, but they were incubated exclusively in
BB4. In the binding reactions, the salt concentration of the
enzyme storage buffers increased the concentration of
NaCl by  1mM for Topo IV, whereas the yTopo II
and hTopo IIa storage buffers increased the NaCl concen-
tration by  50mM.
Atomic force microscopy
Complexes were assembled as described above and diluted
8- to 12-fold in deposition buffer [50mM HEPES (pH
7.5), 5mM MgCl2, 50mM NaCl and 2–5% v/v glycerol]
to a ﬁnal protein:DNA concentration of 60nM:12nM in a
total volume of 20ml (35). The entire 20ml sample was
immediately deposited on a freshly cleaved mica surface
(Spruce Pine Mica Company, Spruce Pine, NC, USA) and
allowed to adsorb for  30s at room temperature before
being gently rinsed with Milli-Q water for 30s. Residual
water was wicked from the mica using a strip of ﬁlter
paper, and the mica was gently blown dry with com-
pressed air (Whoosh-Duster
TM, Control Company,
Houston, TX, USA). Images were captured using
Multimode JV and EV scanners and Nanoscope IIIa
and V controllers (Veeco Metrology, Santa Barbara,
CA, USA). Data were collected using tapping mode in
air. SSS–NCHR (tip radius <5nm) (Nanosensors,
Neuchatel, Switzerland) and AC160TS (tip radius
<10nm) (Olympus, Tokyo, Japan) tapping mode silicon
probes were used for imaging. Both cantilever probes
had spring constants of  42N/m and resonance
frequencies of  300kHz. Images were collected at a rate
of 2–3Hz and had a resolution of 512 512 pixels per
square micron.
Image analysis
AFM images were ﬂattened to correct for the natural
curvature of the mica surface using Nanoscope V
software and converted to bitmap ﬁles using WSxM
software (36). DNA bend angles were measured using
three different techniques: manual tangent overlay, auto-
mated tangent overlay and end-to-end distance (EED)
ﬁtting. Manual tangent overlay, was performed as previ-
ously described (35,37–39). Brieﬂy, we used the angle
measurement tool in ImageJ to measure the angle ( )
between two tangent line segments that were drawn
along the contour of the  50nm DNA fragments
emerging from the  15nm diameter protein (Figures 1D
and 5E). The bend angle ( ) is deﬁned as  =180  
(Figure 1D). Three types of protein–DNA complexes
were identiﬁed: enzyme bound to a long substrate (D1
or D2), enzyme bound to a short substrate (D3, D4, or
D5), and enzyme bound and joining two short substrates
(D3, D4, or D5) (Figure 2). Protein–DNA complexes were
manually selected based on the criteria that only one
protein was bound to the DNA, protein was not bound
to the ends of the DNA, and the bound DNA did not
intersect another DNA molecule. The intrinsic bend
angles of free DNA (substrate D6) were determined as
described (35,38). Brieﬂy, 15nm circles were drawn near
the middle of each DNA molecule to simulate bound
protein and angles were measured as described above for
actual protein–DNA complexes. The measured angles ( )
determined for unbound DNA were all measured to be
<180 . Plotting and statistical analysis was performed
with IGOR Pro software (Wavemetrics, Oswego, OR,
USA). Data were statistically analyzed using the analysis
of variance (ANOVA) and Tukey Tests in IGOR Pro.
Each subset of data for Topo IV, corresponding to differ-
ent substrate and/or buffer conditions, was compared
against all other subsets to ensure that the populations
were statistically indistinguishable in regards to both the
variance (ANOVA) and mean (Tukey Test).
The automated tangent overlay bend angle measure-
ment technique was an automated, image processing
based implementation of the manual tangent overlay pro-
cedure. This program, written in LabVIEW
TM (National
Instruments, Austin, TX, USA), ﬁrst applied a pixel
threshold and adjusted the brightness, contrast, and
g-values of each image such that free DNA, unbound
topoisomerase, and DNA–topoisomerase complex
images were above the background threshold value.
Second, the program applied a size threshold such that
only the DNA–topoisomerase complex images were
above the threshold value, thus ﬁltering out all free
DNA and free topoisomerases from the images.
Rectangular regions containing images of the DNA–topo-
isomerase complexes were extracted and stored as
sub-image ﬁles. Each sub-image window was individually
judged by a human supervisor, who would accept or reject
complexes based on the same criteria used for manual
tangent overlay.
Each selected sub-image was analyzed to determine the
bend angle formed by the two DNA segments emerging
from the topoisomerase. For each DNA–topoisomerase
complex, a circular overlay was ﬁtted to best match the
shape of the enzyme, thus estimating its center and radius.
Additionally, two concentric circles, centered on the
protein, were superimposed on the complex such that
the inner circle radius was 2–4nm larger than the radius
Nucleic Acids Research, 2011,Vol.39, No. 13 5733of the topoisomerase and the outer circle radius was
30–60nm larger than the inner circle. Next, the skeleton
of the DNA was extracted after applying a binary thresh-
old to the image and removing small objects surrounding
the DNA segments. Sections of the DNA skeletons lying
between the two superimposed circles were linearly ﬁtted,
and the ﬁts were extrapolated to the point of intersection
to determine the angle of intersection,  , which was pre-
viously deﬁned as the supplement to the bend angle,  
(Supplementary Figure S1A and Figure 1D). We used
the methods of maximum likelihood and bootstrapping
to determine the mean, standard deviation and error of
the angle distributions.
The EED measurement technique assayed a more
global property of bending by comparing measured
EEDs with simulated EEDs of bent DNA molecules
equilibrated in 2D. We followed the method of Dame
et al. (40) with two modiﬁcations. Brieﬂy, for each DNA
substrate, histograms of the EEDs of simulated DNA
molecules were generated using WLC statistics with a per-
sistence length of 50nm for a range of imposed bend
angles. These histograms were then compared with the
histogram of measured EEDs from the AFM images of
topoisomerase–DNA complexes containing two DNA
molecules joined by a topoisomerase. The  
2 statistic
was calculated using an expression developed speciﬁcally
for Poisson distributed data, shown in Equation (1), where
fðxi, ~ aÞ are the data from the simulated histogram and ni
are data from the histogram of the experimental data (41).
The bend angle was deﬁned as the imposed bend angle of
simulated DNA that minimized the  2
P value.
 2
P ¼
X N
i¼1
2ðfðxi, ~ aÞ niÞ+ð2ni+1Þlog
2ni+1
2fðxi, ~ aÞ+1
     
ð1Þ
This method was modiﬁed to account for the speciﬁc
details of the DNA substrate used in this study and the
binding geometry of type IIA topoisomerases (23,25,26).
As shown in Figure 2, DNA substrates of varying lengths
were used for the AFM imaging. In particular, substrates
in which the restriction fragments were of unequal lengths
could form three possible complexes with a topoisomerase
stabilizing the palindromic 4bp junction: the long
fragment could bind to the shorter fragment with a prob-
ability of 0.5, the long fragment could bind to another
long fragment with a probability of 0.25, or the short
fragment could bind to another short fragment with a
probability of 0.25. We accounted for this ambiguity in
the bound substrates by simulating all possibilities and
combining the simulations with the appropriate statistical
weight (0.5 or 0.25). In other words, each simulated dis-
tribution was made up of 50% long–short, 25% long–long
and 25% long–short DNA complexes.
The second alteration of this method involved
simulating a two-kink model of DNA bending instead of
the one-kink bending model utilized by Dame et al. (40).
In a one-kink model, the DNA is kinked in one position,
creating a ‘V’ shape. In a two-kink model, the DNA is
kinked in two positions, creating a ﬂat-bottomed ‘V’,
where the length of the ﬂat bottom is held constant, and
for the purpose of these simulations was assumed to be
rigid (Rc) (Supplementary Figure S1B). Instead of
imposing one bend of   degrees, we imposed two bends,
each  /2 degrees, on either side of the Rc segment of the
DNA. We held the length constant in the Rc region for
each simulation, but ran the simulation for four different
values of Rc: 0, 2, 4 and 6nm. Then, as in the original
method, we used WLC statistics to model the segments of
the DNA from the location of the bends to the ends of the
DNA molecules. Because crystal structure data indicate
that type IIA topoisomerases bend DNA by imposing
two bends on either side of a straight segment of DNA
(23,25,26,42), we reasoned that the two-kink model of
DNA bending would be more appropriate for our data
than the one-kink model.
In addition to the bend angles determined by comparing
the histograms of simulated data to experimental data, we
also used a  
2 statistic [Equation (2)] to compare the mean
square EEDs for the simulated and experimental data
(43). Here, R2
sim
  
is the mean square EED of the simulated
DNA for a given bend angle, R2   
is the measured mean
square EED, and  
2 is the variance of the mean square
EED measurement. Supplementary Figure S2 shows a
representative histogram of experimental EED data and
the best ﬁt histogram of simulated DNA, as well as the
plots of  2
P as a function of bend angle for the simulated
histogram data and  2
R2 hi as a function of bend angle for
the mean square EEDs.
 2
R2 hi ¼
R2
sim
  
  R2       2
 2 ð2Þ
Single molecule FRET experiments
A custom-built prism-type total internal reﬂection (TIR)
ﬂuorescence microscope based on an Olympus IX71 was
used to measure bend angles at the single-molecule level.
A ﬂow cell was constructed with double-sided tape [SA–S–
1L 0.12mm Grace BioLabs (Bend, OR, USA) Secure-Seal
adhesive double-sided tape] sandwiched between a cover-
slip [Gold Seal (Thermo Scientiﬁc, Portsmouth, NH,
USA) 1 22mm 40mm] and a quartz slide [SPI
(West Chester, PA, USA) 25mm 76mm 1mm]. Both
the coverslip and the quartz slide were cleaned extensively
using NaOH, ethanol and acetone. TIR of the excitation
laser was achieved using a quartz prism [CVI
(Albuquerque, NM, USA) PLBC–5.0–79.5–SS] and
occurred at the interface of the quartz slide and the
buffer in the ﬂow cell. The evanescent wave at the inter-
face generated due to TIR was used to excite ﬂuorescently
labeled substrates within a thin layer of  250nm. The
excitation laser, with a power of  3mW at 532nm
[CrystaLaser (Reno, NV, USA) GCL–025–L–0.5%], was
focused onto an area of  150 150mm
2 to excite
Alexa546 labeled donor substrates. Alexa647 labeled
acceptor substrates were used to detect FRET between
two substrates due to imposed bending by different type
II topoisomerases. Fluorescence was collected by a water
immersion objective with 60 magniﬁcation and 1.2
numerical aperture [Olympus (Center Valley, PA, USA)
UPLSAPO60XWIR]. Additional magniﬁcation of 1.6 in
5734 Nucleic Acids Research, 2011,Vol.39, No. 13the Olympus IX71 was used to obtain a total magniﬁca-
tion of 96 . Excitation light was rejected using a
HQ550LP ﬁlter (Chroma, Bellows Falls, VT, USA).
Donor emission and acceptor emission were separated
using a Dual View [Photometrics (Tucson, AZ, USA)
DV2-SYS with 06-EML2 Optical Filter Set] and
detected using an EMCCD camera [Andor (South
Windsor, CT, USA) DV897DCS–BV]. Andor iQ 1.8
software was used to control the camera and record
movies with 100ms time resolution. Fluorescence
intensities of both donor and acceptor as a function of
time for individual molecules were extracted for further
analysis.
The buffer used in single-molecule FRET experiments
was the same used for ensemble activity assays minus
ATP: 40mM Tris–HCl (pH7.5), 6mM MgCl2,1 m M
DTT, 100mM KOAc, 50mg/ml BSA and 0.1mM
EDTA. For these experiments, a mixture of 25nM
Alexa546 (donor) labeled DNA substrate F1 (Figure
3A), 25nM Alexa647 (acceptor) labeled DNA substrate
F2 (Figure 3A) and 1mM Type IIA topoisomerase was
incubated on ice for 30min. Three microliters of this
mixture was diluted in 1ml buffer, ﬂowed into the ﬂow
cell, and incubated for 10min to immobilize the donor
substrates prior to recording movies. Biotinylated donor
substrates (F2, Figure 3A) were immobilized on the quartz
surface of the ﬂow cell using a streptavidin-biotin linker.
Since the acceptor was on a separate DNA substrate (F1)
we observed FRET only when a topoisomerase bound
both the donor and acceptor substrates and introduced a
bend (Figure 3B). A control experiment with both donor
and acceptor substrates but no topoisomerase showed no
FRET.
RESULTS
Different type IIA topoisomerases simplify topology
to differing degrees
Type IIA topoisomerases have been shown to reduce
the topological complexity of DNA by preferentially
removing knots and catenanes and reducing the absolute
level of supercoiling (15,16). These measures of topology
simpliﬁcation are highly correlated for each type IIA
topoisomerase, suggesting that they are likely governed
by a single underlying process (15). Thus, supercoil relax-
ation measurements are sufﬁcient to conﬁrm the non-
equilibrium activities of these enzymes (16). In order to
verify the non-equilibrium activities of the type IIA topo-
isomerases used for AFM imaging, we measured supercoil
relaxation by Topo IV, yTopo II and hTopo IIa. The
absolute level of supercoiling is reﬂected in the width of
the topoisomer distribution, i.e. the relative abundance of
each topoisomer. The topoisomer distribution can be
resolved on an agarose gel in the presence of chloroquine
as shown in Figure 4A. Individual topoisomers differing
by a single linking number (Lk) ran as distinct bands
in the gel, the relative intensities of which were plotted
to obtain the topoisomer distribution. The width of the
topoisomer distribution is quantiﬁed by the variance
(Lk
2), with reduced absolute levels of supercoiling
corresponding to reduced variances. As previously
observed, the distribution of topoisomers was narrower
for the type IIA topoisomerases than for Topo I, which
generates an equilibrium distribution of topoisomers.
The degree of topological simpliﬁcation was quantiﬁed
by comparing the variances of the type IIA topoisomerase
distributions with that of the Topo IB distribution.
The ratio (R) of the variance of Topo IB to each of the
type IIA topoisomerases was consistent with reported
values (Figure 4B) (15,16). Topo IV shifted the topology
furthest from equilibrium (R=1.9±0.1; mean±SD),
hTopo IIa shifted the topology to an intermediate extent
(R=1.8±0.1), and yTopo II shifted the topology the
least (R=1.12±0.07).
Type IIA topoisomerases impose comparable bend
angles on DNA
The bend angle model posits that the degree of non-
equilibrium topology simpliﬁcation by type IIA topo-
isomerases depends on the extent of G–segment DNA
bending. In order for DNA bending to account for differ-
ences in topology simpliﬁcation, the type IIA topoisom-
erases we investigated would impose signiﬁcantly different
bend angles, ranging from  100  for yTopo II to >300 
for Topo IV (20). To evaluate the feasibility of this model,
we used AFM and single-molecule FRET to determine
the differences in G–segment DNA bending among
type IIA topoisomerases that exhibit a wide range of
non-equilibrium relaxation activities (Figure 4). Figure 5
shows typical AFM images of topoisomerase IIA-DNA
complexes as well as DNA in the absence of protein.
AB
Figure 4. Topology simpliﬁcation by type IIA topoisomerases. (A)
Agarose gel run in the presence of 1mg/ml chloroquine to resolve topo-
isomers. The bands on the gel correspond to the linking numbers (Lk)
of the plasmid DNA. The center band in each lane contains relaxed
DNA and bands on either side contain DNA with Lk of ±1 for each
subsequent band from the center. The topoisomer distributions for
wheat germ Topo I (I), Topo IV (IV), yTopo II (yII) and hTopo IIa
(hIIa) are shown along with negatively supercoiled plasmid DNA (P).
The band at the top of each lane is open circular (nicked) DNA (o/c).
(B) Normalized topoisomer distributions for each topoisomerase.
Points on the graph represent the peak intensity of each band plotted
as a function of the peak location in pixels. Each topoisomerase dis-
tribution was ﬁt to a Gaussian (lines): Topo I (diamonds, black line),
Topo IV (squares, red line), yTopo II (triangles, green line) and
hTopo IIa (circles, blue line).
Nucleic Acids Research, 2011,Vol.39, No. 13 5735We incubated Topo IV with one of two linear DNA
substrates, D1 or D2 (Figure 2), each of which included
a putative Topo IV binding sequence adapted from
Marians and Hiasa (34). The complexes were deposited
on freshly cleaved mica and imaged in air using tapping
mode AFM. These substrates exhibited low binding
afﬁnity under the conditions required for AFM imaging
of protein–DNA complexes (10–60nM enzyme). Since
type IIA topoisomerases have been shown to preferen-
tially bind and stabilize 4bp complementary overhangs
(25), we developed substrates D3 and D4 (Figure 2) that
contained complementary 4bp overhangs to stabilize
binding. This binding conﬁguration further provided a
high degree of speciﬁcity as complexes consisting of two
DNA segments joined by a topoisomerase could be easily
distinguished from topoisomerase binding to individual
short DNA segments in the AFM images. Furthermore,
the sequence of the DNA bound by the topoisomerase in
these tripartite complexes was well deﬁned, as were the
lengths of the DNA segments on either side of the
binding site, thus facilitating further analysis (See
Supplementary Data). Substrates D3 and D4 resulted in
a higher fraction of Topo IV bound to DNA in the AFM
images. Whereas, it is conceivable that these substrates
could affect the protein induced bending, footprinting ex-
periments suggest that the protein protects  34bp (34),
and crystal structures of type IIA topoisomerases bound
to DNA show that bending occurs  5bp away from the
cleavage sites (23,25). Furthermore, statistical analysis
conﬁrmed that the bend angles imposed on intact and
doubly nicked DNA segments by Topo IV were indistin-
guishable (see below).
For all four DNA substrates, we observed DNA
bending when Topo IV was bound (Figures 5A, E and
F). The included angle ( ) between the DNA segments
emerging from the protein was measured as previously
described (35,37–39), and the bend angle ( ) was deﬁned
as the supplement of  , i.e.  =180  –  (Figures 1D and
5E). We determined bend angles for Topo IV bound to the
four DNA substrates described above under several buffer
conditions. Measured bend angles were normally
distributed, and ANOVA and Tukey tests (44) of the
bend angle distributions for intact and cleaved DNA sub-
strates under all buffer conditions indicate that the popu-
lations were statistically indistinguishable (PANOVA and
PTukey>0.05). Hence, all data for Topo IV were
combined and analyzed using maximum likelihood esti-
mation (45) to determine the mean and standard deviation
of the bend angle. We found that Topo IV bent the DNA
by a mean angle of 80±3  with a SD=30±2  (n=242)
(Figure 6A). The uncertainties represent the standard
errors of the mean obtained from bootstrap analysis (46).
In addition to the manual tangent overlay method, we
also used an automated tangent overlay method and an
EED analysis to determine bend angles from the AFM
images. Using the method of automated tangent overlay,
we found that Topo IV bent the DNA by a mean angle
of=100±4  with a SD=35±2  (n=181) (Figure 6B).
Using EED analysis we found that Topo IV bent DNA by
a mean angle of 99±38  (n=242) or 124±38 
AB C
DEF
Figure 5. AFM images of DNA–type IIA topoisomerase complexes. (A) Representative Topo IV–DNA complexes (designated by white arrows).
(B) yTopo II–DNA complexes. (C) hTopo IIa–DNA complexes. (D) DNA in the absence of protein. (E) One DNA–Topo IV complex with the
measured angle ( ) and bend angle ( ) indicated. (F) Three-dimensional representation of the complex from (E). The vertical scale has been expanded
for clarity.
5736 Nucleic Acids Research, 2011,Vol.39, No. 13(n=181), for manually and automatically selected popu-
lations of protein–DNA complexes, respectively.
Since the bend angles measured for Topo IV were inde-
pendent of the DNA substrate, we used substrates D4 and
D5, which is a symmetric version of D4 (Figure 2), to
measure bending by yTopo II and hTopo IIa. Manual
tangent overlay showed that yTopo II imposed a bend
angle of 87±5  with a SD=39±3  (n=251),
automated tangent overlay showed that yTopo II
imposed a bend angle of 103±4  with a SD=40±2 
(n=295), and EED analysis showed that yTopo II
imposed a bend angle of 105±35  (n=251) or
103±35  (n=295), depending on the population of
protein-DNA complexes used (manually or automatically
selected, respectively) (Figures 6C and D). Manual
tangent overlay showed that hTopo IIa imposed a bend
AB
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Figure 6. Distributions of bend angles imposed on DNA by different type IIA topoisomerases. Distribution of bend angles for Topo IV (A)
determined by manual tangent overlay (m=80±3  , s=30±2  , n=242), and (B) determined by automated tangent overlay ( =100±4 ,
  =35±2  , n=181). Distribution of bend angles for yTopo II (C) determined by manual tangent overlay ( =87±5  ,   =39±3  , n=251),
and (D) determined by automated tangent overlay (m=103±4 ,   =40±2  , n=295). Distribution of bend angles for hTopo IIa (E) determined
by manual tangent overlay ( =66±4  ,   =28±3  , n=110), and (F) determined by automated tangent overlay ( =102±5 ,   =37±3  ,
n=269). Curves represent Gaussian distributions with parameters obtained from maximum likelihood ﬁtting of the data with errors determined by
bootstrapping (45,46). Distribution of bend angles for DNA in the absence of protein (G) determined by manual tangent overlay ( =0±1  ,
  =30±4  , n=201), and (H) determined by automated tangent overlay (m=0±1  , s=43±13  , n=247). These curves represent the best ﬁt of
a folded Gaussian distribution [Equation (3)] to the bend angle histograms with means and errors determined by bootstrapping (46–49).
Nucleic Acids Research, 2011,Vol.39, No. 13 5737angle of 66±4  with a SD=28±3  (n=110) (Figures
6E and F), automated tangent overlay showed that
hTopo IIa imposed a bend angle of 102±5  with a
SD=37±3   (n=269), and EED analysis showed that
hTopo IIa imposed a bend angle of 84±32  (n=110) or
127±32  (n=269), depending on the population of
protein–DNA complexes used (manually or automatically
selected, respectively). The measured bend angles for each
topoisomerase using each method are summarized in
Table 1.
To determine the intrinsic bending of DNA on the mica
surface, we imaged a 360bp fragment of linear DNA (sub-
strate D6, Figure 2) in the absence of protein (Figure 5D).
We measured the bending of the DNA from the AFM
images as previously described (35,38). Using ImageJ,
circles were drawn near the middle of each DNA
molecule to simulate bound protein. The bend angles
were then measured using the angle measurement tool in
ImageJ, as described above. Measurements of   were
assigned values <180 , resulting in a folded Gaussian dis-
tribution (47) of bend angles as described by Le Cam et al.
(48) and Cherny et al. (49). The data were well ﬁt by a
folded Gaussian [Equation (3)], returning a mean ( )o f
0±1   and SD (s)o f3 0 ± 4   (n=201) for bend angles
measured using manual tangent overlay and a mean bend
angle of 0±1  and SD=43±13  (n=247) for bend
angles measured by the automated tangent overlay
method (Figures 6G and H).
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In addition to the AFM measurements, we made
single-molecule FRET measurements to estimate the
bend angle imposed on DNA by each topoisomerase.
Figure 7 shows the histograms of FRET efﬁciency
values for each topoisomerase and a graph showing the
relationship between FRET efﬁciency and DNA bend
angle. The substrate we used for these experiments was
the same substrate as used in the crystallization experi-
ments done with yTopo II (25) with a single base change
in the 4bp overhang to disrupt its palindromic symmetry
and a 30bp extension, well separated from the binding
site, to prevent the protein from interacting with the
surface of the slide. The mean FRET efﬁciencies for
Topo IV, yTopo II and hTopo IIa were 0.225±.007
(n=20941), 0.370±.009 (n=28363), and 0.324±.010
(n=26593) (mean±SEM), respectively (Figure 7A).
We calculated the average ﬂuorophore separation (r)
from the measured FRET efﬁciencies using Equation
(4) with a calculated R0 value of 7.4nm±10% for
A
B
Figure 7. FRET efﬁciencies and relationship to DNA bend angle.
(A) Histograms of FRET data for Topo IV (0.225±0.007, n=20941),
yTopo II (0.370±0.009, n=28363) and hTopo IIa (0.324±0.010,
n=26593) (mean ±SEM). (B) Plots showing FRET efﬁciency as a
function of bend angle [Equations (4) and (5)] for the DNA substrate
used in the FRET experiments using R0=7.4, rc=4.8nm, rtot=14nm
and rrise=1.5nm (solid line) and the FRET efﬁciency versus bend angle
relationship when experimental uncertainties, such as uncertainties in R0
(±10%) and rrise (±1.5nm), are taken into account (dashed lines).
Table 1. Bend angles measured from AFM images using four
different analysis techniques and bend angles measured from
single-molecule FRET
Topo
IV ( )
yTopo
II ( )
hTopo
IIa ( )
AFM
Manual tangent
a 80±3 87±5 66±4
Automated tangent
a 100±4 103±4 102±5
EED histogram ﬁt (manual)
b 99±38 105±35 84±32
Mean EED  
2 (manual)
b 102±4 108±7 81±7
EED histogram ﬁt (automated)
b 123±34 103±17 126±25
Mean EED  
2 (automated)
b 119±6 102±4 123±4
Weighted mean of AFM
measurements
94±13 100±7 95±24
Single-molecule FRET 126±18 140±16 136±17
aMean±SEM.
b ±angle at minimum  
2+1, Rc=6nm, see text.
5738 Nucleic Acids Research, 2011,Vol.39, No. 13the Alexa546-Alexa647 ﬂuorophore pair used in the
single-molecule FRET experiments. To calculate the
imposed bend angle, we assumed the DNA geometry
was similar to that observed in crystal structures
(23–25,42). Accordingly, we modeled the bend as two
symmetric bends (with bend angle  /2) on either side of
a short DNA segment of length rc between the two dyes
separated by a total distance along the DNA of rtot
(Figure 3). In the analysis of our single-molecule FRET
data, we included the possibility of a small helical pitch of
the DNA. The inclusion of a signiﬁcant helical pitch was a
feature of the bend angle model. Klenin et al. (20)
determined that the bend angle model was insensitive to
the helical pitch when it exceeded a 9nm helical rise over
150bp, which corresponds to a rise per base pair of only
0.06nm/bp. Because the protein contacts <40bp of DNA,
we estimated that the helical rise would be only on the
order of  3nm over the biologically relevant length of
DNA. We incorporated this DNA rise into the FRET
calculations by introducing an additional term, rrise into
the equation for calculating r. We used a value of
rrise=1.5±1.5nm as the three possible cases representing
zero helical rise, an intermediate 1.5nm rise, and the
 3nm helical rise assumed by the bend angle model
(20). Equation (5) describes the relationship between the
dye separation, r, and the geometry of the bent DNA. We
calculated the separation between dyes on the DNA sub-
strate, rtot=14nm, assuming a length per base of
0.334nm and based on the yTopo II crystal structure we
set rc=4.8nm (25). The resulting relationship between
FRET efﬁciency and the bend angle   is plotted in
Figure 7B. With this model, the computed bend angles
were 126±18  for Topo IV, 140±16  for yTopo II
and 136±17  for hTopo IIa.
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Although these bends are larger than those determined
from the AFM images, the differences in the bend
angles among the topoisomerases are very similar.
These larger bend angles are more consistent with DNA
bends determined from crystal structures (23–25,42).
Importantly, the single-molecule FRET bend angle meas-
urements were made in the same buffer in which the re-
laxation experiments were performed. We have observed
that the composition of the buffer, particularly the ionic
strength, changes not only the afﬁnity but also the bend
angle imposed by the topoisomerases. It is possible that
the AFM deposition buffer, which was optimized to
achieve equilibrated binding of the protein–DNA
complexes onto the mica surface, contributed to the
somewhat lower bend angles measured from the AFM
images. Nevertheless, the FRET data and AFM data
agree that the three Type IIA topoisomerases investigated
here bend DNA to a similar degree.
DISCUSSION
We have shown that the DNA bend angles imposed by
Topo IV, hTopo IIa and yTopo II are similar and are not
correlated with the extent of their topology simpliﬁcation
activities. This result is inconsistent with the bend angle
model, in which the degree of topology simpliﬁcation
scales with the magnitude of the imposed bend angle
(20). The relationship between topology simpliﬁcation
and bend angle determined by Klenin et al. (20) suggests
that Topo IV should impose the largest bend
angle ( 310 ), hTopo IIa should impose a smaller angle
( 230 ) and yTopo II should impose the smallest angle
( 100 ). (A detailed description of the derivation of the
relationship between predicted bend angle and topology
simpliﬁcation is described in the Supplementary Data.)
However, our AFM and single-molecule FRET data
indicate that the three topoisomerases impose similar
bend angles. Our AFM data suggested that yTopo II
imposed the largest bend angle (100±7 ), followed by
hTopo IIa (95±24 ), and lastly Topo IV (94±13 ).
Our FRET data suggest larger angles of 140±16  for
yTopo II, 136±17  for hTopo IIa and 126±18  for
Topo IV (Table 1, Figure 8). Within each technique, all
three bend angles are within 15  of one another, which we
consider to be within our experimental uncertainty. Also,
the angles follow the opposite order of the predicted bend
angles, and there is no evidence of the  3–fold difference
in bend angles required by the bend angle model (20). This
leads us to conclude that while DNA bending is prevalent
in all topoisomerases and may be an indicator of some
conserved topology shifting mechanism, bending alone,
within the context of the bend angle model, cannot
Figure 8. Comparison of measured and predicted bend angles imposed
by type IIA topoisomerases. Shown is a plot of topology simpliﬁcation
ability (R) as a function of measured and predicted bend angles for
Topo IV (red squares), yTopo II (green triangles) and hTopo IIa (blue
circles). Bend angles measured from AFM images (outlined shapes) and
FRET efﬁciencies (dashed outlined shapes) are plotted along with pre-
dicted bend angles extrapolated from the bend angle model (20) (solid
shapes) using the non-equilibrium unknotting and supercoil relaxation
data from Rybenkov et al. (15). (See Supplementary Data for a detailed
description of the derivation of this relationship).
Nucleic Acids Research, 2011,Vol.39, No. 13 5739solely explain topology simpliﬁcation by type IIA
topoisomerases.
Though AFM measurements have consistently been
shown to accurately measure protein–DNA interactions
and conformations (35,37,50–53), we veriﬁed that depos-
ition conditions favored 2D equilibration of the DNA
molecules on the mica surface and hence that the data
accurately represent the conformations of both the DNA
and the protein-DNA complexes (54–56). 2D DNA equili-
bration is further supported by the agreement of bend
angles determined by tangent measurements (both
manual and automated) and EED measurements.
Furthermore, the lack of correlation between the height
of the DNA segments emerging from the protein and the
measured bend angle is additional evidence that the
protein–DNA complex equilibrated in 2D (see
Supplementary Data).
Although direct visualization of DNA–type IIA topo-
isomerase complexes and measurement of bend angles
have not been previously reported, other methods, such
as protein–DNA co-crystalization, single-molecule DNA
manipulation and DNA cyclization have been employed
to probe topoisomerase-induced DNA bending. Crystal
structures of several type IIA topoisomerase–DNA
complexes have been reported in the literature. These
include the TOPRIM fold, which is a conserved domain
required for DNA cleavage, and primary DNA-binding
domain of yTopo II (25,26), the breakage-reunion and
TOPRIM domains of S. pneumoniae Topo IV in the
presence of the quinolones moxiﬂoxacin and clinaﬂoxacin
(23), and the ParE28-ParC58 fusion of A. baumannii Topo
IV in the presence of the quinolone moxiﬂoxacin (24). The
yTopo II–DNA structure reported a DNA bend angle of
 150 , and we estimated similar bend angles from the
S. pneumoniae Topo IV–DNA crystal structure and the
A. baumannii Topo IV–DNA crystal structure. In fact,
the bend angle imposed on DNA by A. baumannii Topo
IV, which has a high degree of sequence identity (61%)
with E. coli Topo IV, was slightly smaller than the bend
angle imposed on DNA by yTopo II, which is consistent
with our results.
Our measurement of the bend angle imposed by
yTopo II from AFM images (100±7 ) is smaller than
the angle measured from the crystallized protein–DNA
complex, though the angle measured from FRET experi-
ments (140±16 ) is much closer to this value ( 150 )
(25). The discrepancy could arise from several effects,
including different buffer conditions used in AFM and
single-molecule FRET experiments that could have
affected the bend angles. FRET experiments were per-
formed under the exact buffer conditions as the relaxation
assays, whereas AFM experiments had to be performed in
a buffer optimized for AFM deposition. We observed that
monovalent salt concentration, in particular, had a strong
inﬂuence on bend angle in our single-molecule FRET ex-
periments (data not shown). Regardless of the
discrepancies, our AFM and FRET data both show that
type IIA topoisomerases bend DNA to a similar extent.
This result is consistent with published DNA–topoisom-
erase crystal structures, which show that all crystallized
protein–DNA complexes reveal comparable DNA
bending by type IIA topoisomerases from very different
organisms (23–26,42). Though the exact role of DNA
bending in the mechanism of type IIA topoisomerases
has not been determined, one study suggests that these
enzymes require the DNA to be under considerable
strain in order for cleavage to occur (57). Perhaps DNA
bending provides the necessary distortion of the double
helix that allows the cleavage reaction and thereby the
relaxation reaction to proceed.
The extent of DNA bending by Topo IV has also been
estimated from single-molecule measurements of the size
of plectonemic loops in supercoiled DNA with Topo IV
bound, which indicate that Topo IV imposes a radius of
curvature of  6.4nm onto DNA (27). The radius of
curvature can be related to a bend angle given assump-
tions about the distance over which the circular curvature
approximation holds. A reasonable assumption is that the
radius of curvature holds for an arc length equal to the
number of DNA base pairs that interact with the protein.
Estimating this length from footprinting data showing
 34bp of protected DNA (34), we calculated the bend
angle could be as large as  135  (assuming the protein
bends the DNA over 45bp) or as small as  75 
(assuming the protein bends the DNA over 25bp). Our
measured angle for Topo IV is consistent with this range.
It should also be noted that the radius of curvature
determined from the magnetic tweezers experiment is not
consistent with a bend angle >180  and certainly not as
large as the  310  angle suggested by the bend angle
model. DNA bending by type IIA topoisomerases has
also been probed through DNA cyclization experiments
(19,21). Though these experiments have shown that
Topo IV bends DNA and yTopo II does not, we noted
in our AFM images, and others have observed (22), that
type IIA topoisomerases have a high afﬁnity for DNA
ends. This renders the cyclization data difﬁcult to interpret
since the presence of a topoisomerase on the ends would
likely confound the ligation reaction necessary to achieve
cyclization.
Though the bend angle model was developed to explain
non-equilibrium topology simpliﬁcation, the sharp DNA
bending predicted by the model has other implications.
Klenin et al. (20) used Monte Carlo simulations to calcu-
late the effects of sharply bent G–segment DNA on topo-
isomerase binding and activity. Many of these predictions
have been addressed in subsequent publications, but their
signiﬁcance with respect to the bend angle model has not
been discussed. For instance, the bend angle model
suggests that a sharp bend imposed on DNA by
Topo IV would result in a twenty fold higher binding
afﬁnity for positively supercoiled [(+)sc] DNA than for
negatively supercoiled [(–)sc] DNA. However, the
binding afﬁnity of Topo IV for (+)sc and (–)sc DNA is
the same or at most a factor of  3 larger for (+)sc DNA
(58–60). A large bend angle imposed by Topo IV would
also provide a mechanism to explain the higher efﬁciency
of Topo IV in relaxing (+)sc DNA than (–)sc DNA (58–
60). However, recent work suggests that chiral discrimin-
ation by Topo IV results from differences in processivity
rather than initial binding differences (59). Moreover,
hTopo IIa has also been shown to relax (+)sc DNA an
5740 Nucleic Acids Research, 2011,Vol.39, No. 13order of magnitude more efﬁciently than (–)sc DNA, yet
its binding afﬁnity is slightly higher for (–)sc DNA (61).
The bend angle model also predicts that Topo IV should
localize at apices of supercoils 87% of the time for (–)
supercoils, but only 28% of the time for (+) supercoils
(20). Whereas this prediction has not been directly
tested, data from magnetic tweezers pulling assays
suggest that Topo IV has a 50% or higher afﬁnity for
(+) supercoil plectoneme apices (27). Furthermore,
recent simulation data using an improved WLC model
for DNA has shown that a DNA hairpin, i.e. a sharp
bend formed by a topoisomerase, is not sufﬁcient to re-
produce the experimentally observed degree of topology
simpliﬁcation (28,29). Measurements of the DNA circle
size dependence of non-equilibrium relaxation provide
additional evidence suggesting that the bend angle model
does not completely describe non-equilibrium topological
relaxation (6,16,21). The impact of DNA bending, and
therefore the efﬁciency of the non-equilibrium relaxation
process, would be expected to increase as the DNA circle
size decreases. However, experiments with yTopo II and
Topo IV show that the topology simpliﬁcation activity
decreases with circle size for small DNA circles and is
independent of circle size for larger DNA circles. The
ensemble of the available evidence from previous studies
and from the measurements of the bend angle presented
here suggests that the bend angle model cannot fully
account for the observed non-equilibrium relaxation
activity of type IIA topoisomerases. However, it is
possible that non-equilibrium relaxation results from G–
segment bending in combination with a second mechan-
ism. All three topoisomerases were found to impose com-
parable bends onto DNA, which suggests that the bend
angle model is incapable of explaining the measured dif-
ferences between the topology simpliﬁcation abilities of
these three enzymes. However, these bend angles are
somewhat consistent with the degree of bending
expected from the least capable topology simpliﬁer,
yTopo II. Thus, it is conceivable that DNA bending is a
conserved mechanism that is able to account for the base
level of topology simpliﬁcation achievable by type IIA
topoisomerases. Further levels of topology simpliﬁcation,
as found in Topo IV and hTopo IIa, must arise from an
additional enzyme speciﬁc mechanism, likely unrelated to
DNA bending.
Several other models have been proposed to explain the
topology simpliﬁcation mechanism of type IIA topoisom-
erases (22). A tracking model proposes that the enzyme
binds to a DNA crossing and tracks along the DNA to
trap T–segments that are catenated or knotted (15).
However, an experiment that placed tightly bound
protein ‘roadblocks’ at several locations along supercoiled
circular DNA did not affect non-equilibrium supercoil re-
laxation (16). A three segment binding model postulates
that the topoisomerase binds two potential T–segments
prior to selecting one for strand-passage based on local
geometry (21). However, this model predicts an asymmet-
ric removal of positive versus negative supercoils that
would result in a skewed topoisomer distribution, which
we did not observe for any of the type IIA topoisom-
erases studied (Figure 4). Other studies have also failed
to detect asymmetric supercoil removal by type IIA topo-
isomerases (16), so while this model may hold in certain
cases, it does not explain the more general mechanism of
topology simpliﬁcation. Two compelling possibilities are
the hooked juxtaposition model and the kinetic proofread-
ing model. The hooked juxtaposition model postulates
that type IIA topoisomerases detect and relax speciﬁc
juxtapositions of catenated, knotted and supercoiled
DNA in which the G– and T–segments are bent toward
one another (17). Simulations based on lattice and WLC
models indicate that strand passage at these hooked juxta-
positions is sufﬁcient to produce non-equilibrium
topology simpliﬁcation (28,29,62–64). The kinetic proof-
reading model suggests that upon binding to the G–
segment of DNA and encountering an initial T–segment,
the topoisomerase becomes transiently activated, perhaps
by binding one of the two ATP molecules. The T–segment
is released and strand passage will occur if a second T–
segment is captured while the enzyme remains in the active
state (18,65). It is possible that one of these models,
perhaps coupled with the small effect arising from the
bend angles imposed by the topoisomerase, could
account for the non-equilibrium topology simpliﬁcation
activity of type IIA topoisomerases. The relatively sharp
bend imposed on the G–segment DNA by type IIA topo-
isomerases is consistent with the hooked juxtaposition
model, though it remains to be determined if bent T–
segments are preferentially captured and passed. Further
experiments are necessary to test these models to deter-
mine which, if either, can explain this fascinating
phenomenon.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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